Developer docs
API playgroundTry for free, no card

Search company profiles

OPHTECS

Full company profile

uuid002fz6i

Namestring
OPHTECS
Legal namestring
株式会社オフテクス
Websiteurl
ophtecs.co.jp
Company typeenum
Private
Founded yearint
1981
Descriptiontext

OPHTECS Corporation (株式会社オフテクス) is a privately held Japanese manufacturer founded in 1981 and headquartered in Kobe, with additional offices in Tokyo, Nagoya, Fukuoka, and Toyooka. The company develops, manufactures, sells, and exports contact lens care products and ophthalmic pharmaceutical products, organized into four primary brands: cleadew for soft contact lens care solutions (including one-step povidone-iodine disinfection tablets), BIOCLEN for O2/hard contact lens care and enzymatic cleaning systems, Teare for over-the-counter eye drops (artificial tears, antihistamine, antibacterial), and Teare Contact for contact lens-compatible eye drops and application solutions. The product range also extends to veterinary eye care products for dogs and cats and the Vue Uno Supreme scleral lens, a medical device for patients with irregular corneas or severe dry eye.

The company's underlying technology is centered on ophthalmic formulation chemistry, including povidone-iodine based disinfection systems, enzyme-based protein removal, hyaluronic acid and chondroitin sulfate moisturizing formulations, and sulfamethoxazole-based antibacterial eye drops at maximum approved concentration. Several products are classified as highly controlled medical devices (高度管理医療機器) in Japan, providing regulatory barriers to entry. The scleral lens product line and its dedicated care accessories are sold exclusively through ophthalmology clinics and dispensing pharmacies, while mass-market eye drops and contact lens care products are distributed through drugstores and pharmacies.

OPHTECS operates a sales-led go-to-market model with a multi-channel distribution structure targeting both healthcare providers (B2B) and end consumers (B2C). Revenue is generated through hardware/product sales across consumer eye care, contact lens care, veterinary ophthalmic products, and specialized medical devices. The company engages in brand-building through sports sponsorships (Kobe Storks, a B.League basketball team), IP collaborations (Demon Slayer campaign), and community event sponsorships in the Kansai region. All operations are domestic to Japan, with no disclosed international expansion, public listing, or external funding.

Short descriptiontext

OPHTECS is a privately held Japanese manufacturer founded in 1981 that develops, manufactures, and sells contact lens care products, ophthalmic eye drops, veterinary eye care, and scleral lenses under the cleadew, BIOCLEN, and Teare brands, distributing through clinics, specialty stores, and pharmacies across Japan.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersShimbashi, Japan
HQ citystring
Shimbashi
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contact lens care, ophthalmic pharmaceuticals, eye drop solutions, scleral contact lenses, veterinary eye care
Industry2 codes
1Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)
CodeHLAHAJAEPrimaryYes
2Ocular Drug Delivery Devices (Eye Droppers/Inserts)
CodeHLAHAIALPrimaryNo
NAICS code1 code
  • Ophthalmic Goods Manufacturing339115
SIC code1 code
  • Ophthalmic Goods3851
Product category
Contact Lens Care Products
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Contact Lens Care Products
TypeHardware Sales
Description

OPHTECS manufactures and sells contact lens care solutions including cleaning, disinfecting, and storage products for both soft and hard contact lenses. Revenue is generated through product sales to consumers via retail channels and to healthcare providers.

ophtecs.co.jp
2Eye Drops and Ophthalmic Products
TypeHardware Sales
Description

Sale of over-the-counter eye drops for dry eye, allergies, and eye infections. Products include artificial tears, antihistamine drops, and antibacterial formulations for adults and children.

ophtecs.co.jp
3Veterinary Ophthalmic Products
TypeHardware Sales
Description

Specialized eye care products for dogs and cats, including artificial tears and cleansing solutions for animal use.

ophtecs.co.jp
4Scleral Lenses
TypeHardware Sales
Description

Custom-fitted scleral contact lenses sold through ophthalmology clinics for patients requiring specialized vision correction.

ophtecs.co.jp
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1cleadew (クリアデュー)
Description

Soft contact lens care solutions including cleadew Hydro One-Step, Pro Care Solution, and Repair Solution products

ophtecs.co.jp
+3 more records
Core offering1 text field

OPHTECS develops, manufactures, and sells contact lens care products (cleaning, disinfecting, and storage solutions) for both soft and O2/hard contact lenses, alongside ophthalmic pharmaceutical products including artificial tears, antihistamine eye drops, and antibacterial eye drops. The company also produces scleral contact lenses for patients with irregular corneas and veterinary ophthalmic products for dogs and cats.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

OPHTECS is a contact lens care product manufacturer offering a comprehensive portfolio organized into four main brands: cleadew (クリアデュー) for soft contact lens care solutions including the Hydro One-Step system, Pro Care Solution, and Repair Solution; BIOCLEN (バイオクレン) for both soft and O2/hard contact lens care including One Ultra Moist, Monocare Moist, and BioL care systems; Teare (ティアーレ) for eye drops including the dual-function Teare W, antibacterial eye drops, and children's formulas; and Teare Contact (ティアーレ _contact) for contact lens-compatible eye drops and application solutions. The company also offers O2/hard lens-specific products, sub-items like protein removal tablets and cleaners, and the View No Supreme scleral lens. Their product lines are categorized by lens type (soft, O2/hard), application method (one-step, two-liquid), and purpose (cleaning, disinfection, protein removal, moisturizing), with products ranging from daily care solutions to specialized treatments for dry eyes, allergies, and bacterial infections.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Kobe Storks (神戸ストークス)
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-07-01
Description

OPHTECS has maintained a Silver Partner sponsorship with the Kobe Storks professional basketball team since 2020. The partnership provides brand visibility at games and events, aligning with the company's focus on Kobe and the Kansai region. The team achieved B2 League championship in 2025-26 season and is entering the new B.LEAGUE PREMIER top division.

ophtecs.co.jp
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global ophthalmic goods manufacturer with major contact lens care solution brands (Renu, Biotrue) that compete directly with OPHTECS's cleadew and BIOCLEN product lines in Japan and worldwide.

TypeDirect peer
Description

Leading Japanese ophthalmology-focused pharmaceutical company offering prescription and OTC eye drops, competing with OPHTECS's Teare brand in ophthalmology clinics and pharmacies.

TypeDirect peer
Description

Japanese company with a contact lens and eyecare division (HOYA Vision Care) producing specialty lenses, parallel to OPHTECS's scleral lens and contact lens care business in the Japanese market.

TypeDirect peer
Description

Japanese consumer healthcare company offering eye drops and personal care products through drugstore channels, competing with OPHTECS's Teare OTC eye drops in the Japanese mass market.

TypeBroad incumbent
Description

Leading global eye care company offering Opti-Free and AOSept contact lens care solutions, directly competing with OPHTECS in the soft contact lens disinfection category.

TypeBroad incumbent
Description

Markets ACUVUE contact lenses and the COMPLETE contact lens care solution brand, a major global competitor to OPHTECS in lens care products.

TypeDirect peer
Description

Japanese specialty contact lens and lens care manufacturer, similarly focused on hard/RGP and specialty lens care products, overlapping with OPHTECS's BIOCLEN and scleral lens portfolio.

TypeDirect peer
Description

Japanese consumer healthcare company with a contact lens care product line (including Smile) that competes with OPHTECS's cleadew and BIOCLEN solutions in the mass drugstore channel.

TypeBroad incumbent
Description

Previously an independent contact lens care brand (now under Johnson & Johnson), offering the COMPLETE multi-purpose solution, a long-standing global competitor to OPHTECS's soft lens care products.

TypeDirect peer
Description

Major Japanese OTC ophthalmic pharmaceutical company offering eye drops and contact lens care products, directly competing with OPHTECS's Teare line in the Japanese drugstore channel.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OPHTECS

Contact Lens Care Productsophtecs.co.jp

OPHTECS is a privately held Japanese manufacturer founded in 1981 that develops, manufactures, and sells contact lens care products, ophthalmic eye drops, veterinary eye care, and scleral lenses under the cleadew, BIOCLEN, and Teare brands, distributing through clinics, specialty stores, and pharmacies across Japan.

What OPHTECS does

OPHTECS Corporation (株式会社オフテクス) is a privately held Japanese manufacturer founded in 1981 and headquartered in Kobe, with additional offices in Tokyo, Nagoya, Fukuoka, and Toyooka. The company develops, manufactures, sells, and exports contact lens care products and ophthalmic pharmaceutical products, organized into four primary brands: cleadew for soft contact lens care solutions (including one-step povidone-iodine disinfection tablets), BIOCLEN for O2/hard contact lens care and enzymatic cleaning systems, Teare for over-the-counter eye drops (artificial tears, antihistamine, antibacterial), and Teare Contact for contact lens-compatible eye drops and application solutions. The product range also extends to veterinary eye care products for dogs and cats and the Vue Uno Supreme scleral lens, a medical device for patients with irregular corneas or severe dry eye.

The company's underlying technology is centered on ophthalmic formulation chemistry, including povidone-iodine based disinfection systems, enzyme-based protein removal, hyaluronic acid and chondroitin sulfate moisturizing formulations, and sulfamethoxazole-based antibacterial eye drops at maximum approved concentration. Several products are classified as highly controlled medical devices (高度管理医療機器) in Japan, providing regulatory barriers to entry. The scleral lens product line and its dedicated care accessories are sold exclusively through ophthalmology clinics and dispensing pharmacies, while mass-market eye drops and contact lens care products are distributed through drugstores and pharmacies.

OPHTECS operates a sales-led go-to-market model with a multi-channel distribution structure targeting both healthcare providers (B2B) and end consumers (B2C). Revenue is generated through hardware/product sales across consumer eye care, contact lens care, veterinary ophthalmic products, and specialized medical devices. The company engages in brand-building through sports sponsorships (Kobe Storks, a B.League basketball team), IP collaborations (Demon Slayer campaign), and community event sponsorships in the Kansai region. All operations are domestic to Japan, with no disclosed international expansion, public listing, or external funding.

OPHTECS firmographics

Firmographics
Name
OPHTECS
Legal name
株式会社オフテクス
Website
https://ophtecs.co.jp
Company type
Private
Founded year
1981
Operating status
Operating
Short description
OPHTECS is a privately held Japanese manufacturer founded in 1981 that develops, manufactures, and sells contact lens care products, ophthalmic eye drops, veterinary eye care, and scleral lenses under the cleadew, BIOCLEN, and Teare brands, distributing through clinics, specialty stores, and pharmacies across Japan.
Ownership category
akta.pro rank

OPHTECS industry classification

Industry
Product category
Contact Lens Care Products
NAICS
Ophthalmic Goods Manufacturing (339115)
SIC
Ophthalmic Goods (3851)
akta.pro primary industry
Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions) (HLAHAJAE)
akta.pro secondary industry
Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

Keywords

  • Contact lens care
  • Ophthalmic pharmaceuticals
  • Eye drop solutions
  • Scleral contact lenses
  • Veterinary eye care

Where OPHTECS is headquartered

Location

Headquarters

HQ city
Shimbashi
HQ country
Japan
HQ region
Asia

Offices5 records

Markets served

OPHTECS business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Contact Lens Care Products: OPHTECS manufactures and sells contact lens care solutions including cleaning, disinfecting, and storage products for both soft and hard contact lenses. Revenue is generated through product sales to consumers via retail channels and to healthcare providers.
  2. Eye Drops and Ophthalmic Products: Sale of over-the-counter eye drops for dry eye, allergies, and eye infections. Products include artificial tears, antihistamine drops, and antibacterial formulations for adults and children.
  3. Veterinary Ophthalmic Products: Specialized eye care products for dogs and cats, including artificial tears and cleansing solutions for animal use.
  4. Scleral Lenses: Custom-fitted scleral contact lenses sold through ophthalmology clinics for patients requiring specialized vision correction.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

OPHTECS product offering

Product offering

Core offering

OPHTECS develops, manufactures, and sells contact lens care products (cleaning, disinfecting, and storage solutions) for both soft and O2/hard contact lenses, alongside ophthalmic pharmaceutical products including artificial tears, antihistamine eye drops, and antibacterial eye drops. The company also produces scleral contact lenses for patients with irregular corneas and veterinary ophthalmic products for dogs and cats.

Product overview

OPHTECS is a contact lens care product manufacturer offering a comprehensive portfolio organized into four main brands: cleadew (クリアデュー) for soft contact lens care solutions including the Hydro One-Step system, Pro Care Solution, and Repair Solution; BIOCLEN (バイオクレン) for both soft and O2/hard contact lens care including One Ultra Moist, Monocare Moist, and BioL care systems; Teare (ティアーレ) for eye drops including the dual-function Teare W, antibacterial eye drops, and children's formulas; and Teare Contact (ティアーレ _contact) for contact lens-compatible eye drops and application solutions. The company also offers O2/hard lens-specific products, sub-items like protein removal tablets and cleaners, and the View No Supreme scleral lens. Their product lines are categorized by lens type (soft, O2/hard), application method (one-step, two-liquid), and purpose (cleaning, disinfection, protein removal, moisturizing), with products ranging from daily care solutions to specialized treatments for dry eyes, allergies, and bacterial infections.

Differentiator

Problem solved

Functional benefit

Brands

  • cleadew (クリアデュー): Soft contact lens care solutions including cleadew Hydro One-Step, Pro Care Solution, and Repair Solution products
  • BIOCLEN (バイオクレン)
  • Teare (ティアーレ)
  • Teare Contact (ティアーレ コンタクト)

Companies that use OPHTECS

Customer profile

Segments4 records

Ideal customer profiles4 records

OPHTECS technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

OPHTECS partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Kobe Storks (神戸ストークス)minorGTM or Marketing Partner · 1 July 2026OPHTECS has maintained a Silver Partner sponsorship with the Kobe Storks professional basketball team since 2020. The partnership provides brand visibility at games and events, aligning with the company's focus on Kobe and the Kansai region. The team achieved B2 League championship in 2025-26 season and is entering the new B.LEAGUE PREMIER top division.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

OPHTECS competitors and assessment

Company assessment

Broad incumbents

  • Bausch + Lomb: Global ophthalmic goods manufacturer with major contact lens care solution brands (Renu, Biotrue) that compete directly with OPHTECS's cleadew and BIOCLEN product lines in Japan and worldwide.
  • Alcon: Leading global eye care company offering Opti-Free and AOSept contact lens care solutions, directly competing with OPHTECS in the soft contact lens disinfection category.
  • Johnson & Johnson Vision: Markets ACUVUE contact lenses and the COMPLETE contact lens care solution brand, a major global competitor to OPHTECS in lens care products.
  • AMO (Abbott Medical Optics): Previously an independent contact lens care brand (now under Johnson & Johnson), offering the COMPLETE multi-purpose solution, a long-standing global competitor to OPHTECS's soft lens care products.

Direct peers

  • Santen Pharmaceutical: Leading Japanese ophthalmology-focused pharmaceutical company offering prescription and OTC eye drops, competing with OPHTECS's Teare brand in ophthalmology clinics and pharmacies.
  • HOYA Corporation: Japanese company with a contact lens and eyecare division (HOYA Vision Care) producing specialty lenses, parallel to OPHTECS's scleral lens and contact lens care business in the Japanese market.
  • Kobayashi Pharmaceutical: Japanese consumer healthcare company offering eye drops and personal care products through drugstore channels, competing with OPHTECS's Teare OTC eye drops in the Japanese mass market.
  • Menicon: Japanese specialty contact lens and lens care manufacturer, similarly focused on hard/RGP and specialty lens care products, overlapping with OPHTECS's BIOCLEN and scleral lens portfolio.
  • Lion Corporation: Japanese consumer healthcare company with a contact lens care product line (including Smile) that competes with OPHTECS's cleadew and BIOCLEN solutions in the mass drugstore channel.
  • Rohto Pharmaceutical: Major Japanese OTC ophthalmic pharmaceutical company offering eye drops and contact lens care products, directly competing with OPHTECS's Teare line in the Japanese drugstore channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

OPHTECS social profiles

Digital presence

OPHTECS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OPHTECS leadership team

Management profile

Number of profiles

OPHTECS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OPHTECS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OPHTECS

What does OPHTECS do?

OPHTECS develops, manufactures, and sells contact lens care products (cleaning, disinfecting, and storage solutions) for both soft and O2/hard contact lenses, alongside ophthalmic pharmaceutical products including artificial tears, antihistamine eye drops, and antibacterial eye drops. The company also produces scleral contact lenses for patients with irregular corneas and veterinary ophthalmic products for dogs and cats.

Is OPHTECS a public or private company?

OPHTECS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was OPHTECS founded?

OPHTECS was founded in 1981.

Where is OPHTECS based?

OPHTECS is headquartered in Shimbashi, Japan, in the Asia region.

How does OPHTECS make money?

Four revenue lines are on record. Contact Lens Care Products are the primary driver. The others are eye Drops and Ophthalmic Products, veterinary Ophthalmic Products and scleral Lenses.

Who are OPHTECS's main competitors?

Broad incumbents on record are Bausch + Lomb, Alcon, Johnson & Johnson Vision and AMO (Abbott Medical Optics). Direct peers are Santen Pharmaceutical, HOYA Corporation, Kobayashi Pharmaceutical, Menicon, Lion Corporation and Rohto Pharmaceutical.

Does OPHTECS have an API?

No public API is recorded for OPHTECS.

What industry is OPHTECS in?

OPHTECS's product category is Contact Lens Care Products. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions), with a secondary code of HLAHAIAL, Ocular Drug Delivery Devices (Eye Droppers/Inserts). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireDas globale Team von OPHTECS begrüßt Dr. Schnider, eine der einflussreichsten Frauen in der optischen Industrie und eine der prominentesten Kontaktlinsenforscherinnen und -ausbilderinnen der WeltOPHTECS Corporation, a Kobe-based company that researches, develops, produces, and markets contact lens care products, has signed an advisory contract with Dr. Cristina M. Schnider, who will serve as Senior Director, Global Medical Affairs. Dr. Schnider, recognized as one of the 50 most influential women in the optical industry and a member of the International Society for Contact Lens Research, is expected to strengthen the company's R&D efforts around new contact lens care products and expand its global professional relations activities.PR NewswireL'équipe internationale d'OPHTECS accueille le Dr Schnider, l'une des femmes les plus influentes du secteur de l'optique et l'une des chercheuses et éducatrices les plus éminentes au monde dans le domOPHTECS Corporation, a Kobe-based company that researches, develops, produces, and commercializes contact lens care products, has signed a consulting contract with Dr. Cristina M. Schnider as Principal Senior Director of International Medical Affairs. Dr. Schnider, described as one of the 50 most influential women in the optical sector and a member of the International Society for Contact Lens Research, will help strengthen the company's R&D for new contact lens care products and its global academic and professional relations activities.PR NewswireEl equipo global de OPHTECS da la bienvenida a la doctora SchniderOPHTECS Corporation, a Kobe-based company that researches, develops, produces, and commercializes contact lens care products, has signed an advisory contract with Dr. Cristina M. Schnider, appointing her as Senior Director of Global Medical Affairs effective January 2023. Dr. Schnider is recognized as one of the most influential women in the optical industry and a leading contact lens researcher and educator. The appointment is intended to strengthen OPHTECS's R&D efforts for new contact lens care products and enhance its global scientific and professional relations activities.PR NewswireOPHTECS Global Team Welcomes Dr. Schnider, One of Most Influential Women in Optical Industry and One of World's Most Prominent Contact Lens Researchers and EducatorsOPHTECS Corporation, a Kobe-based contact lens care products company, has signed an advisory contract with Dr. Cristina M. Schnider to serve as Senior Director, Global Medical Affairs. Dr. Schnider is recognized as one of the 50 most influential women in the optical industry and a member of the International Society for Contact Lens Research. The appointment is intended to strengthen OPHTECS's research and development of new lens care products and its global academic activities.South China Morning PostOphtecs eyes simplification of contact lens care with innovative productsJapanese firm Ophtecs develops contact lens care products, including povidone iodine disinfecting systems like cleadew. The company aims to expand into mainland China, South Korea, Taiwan, and Southeast Asia, targeting speciality contact lens users.PR NewswireOPHTECS, ein bedeutender japanischer Produzent von Kontaktlinsenlösungen, kauft niederländischen Kontaktlinsen-HerstellerOPHTECS Corporation, a Japanese contact lens solution manufacturer based in Kobe, has acquired 100% of Dutch contact lens maker Microlens Contactlens Technology B.V., making it a wholly-owned subsidiary to be renamed OPHTECS Europe B.V. in January 2019. The acquisition aims to create synergies between OPHTECS's existing European distributor network and Microlens's customer base in Benelux countries and Germany, while also seeking to reduce costs and improve efficiency in procurement, transport, and logistics. As part of its medium-term "Breakthrough 2021" business plan, OPHTECS intends to use this acquisition to strengthen its European operations and target 20% of total sales from overseas markets by 2021.